1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Haemophilia A 1.2.3 Haemophilia B 1.3 Market by Application 1.3.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Perspective (2017-2028) 2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Growth Trends by Region 2.2.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Region (2017-2022) 2.2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Region (2023-2028) 2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Dynamics 2.3.1 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Trends 2.3.2 Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers 2.3.3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges 2.3.4 Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue 3.1.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue (2017-2022) 3.1.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue 3.4 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio 3.4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2021 3.5 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players Head office and Area Served 3.6 Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service 3.7 Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Type 4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Type (2017-2022) 4.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2023-2028) 5 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Application 5.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Application (2017-2022) 5.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028) 6.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) 6.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028) 7.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) 7.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028) 8.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028) 9.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) 9.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028) 10.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.1.4 Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.1.5 Pfizer Recent Development 11.2 Novo Nordisk 11.2.1 Novo Nordisk Company Detail 11.2.2 Novo Nordisk Business Overview 11.2.3 Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.2.4 Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.2.5 Novo Nordisk Recent Development 11.3 Baxalta 11.3.1 Baxalta Company Detail 11.3.2 Baxalta Business Overview 11.3.3 Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.3.4 Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.3.5 Baxalta Recent Development 11.4 Bayer 11.4.1 Bayer Company Detail 11.4.2 Bayer Business Overview 11.4.3 Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.4.4 Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.4.5 Bayer Recent Development 11.5 Biogen 11.5.1 Biogen Company Detail 11.5.2 Biogen Business Overview 11.5.3 Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.5.4 Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.5.5 Biogen Recent Development 11.6 CSL Behring 11.6.1 CSL Behring Company Detail 11.6.2 CSL Behring Business Overview 11.6.3 CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.6.4 CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.6.5 CSL Behring Recent Development 11.7 Emergent Biosolutions 11.7.1 Emergent Biosolutions Company Detail 11.7.2 Emergent Biosolutions Business Overview 11.7.3 Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.7.4 Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.7.5 Emergent Biosolutions Recent Development 11.8 Spark therapeutics 11.8.1 Spark therapeutics Company Detail 11.8.2 Spark therapeutics Business Overview 11.8.3 Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.8.4 Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.8.5 Spark therapeutics Recent Development 11.9 Uniqure 11.9.1 Uniqure Company Detail 11.9.2 Uniqure Business Overview 11.9.3 Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Introduction 11.9.4 Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) 11.9.5 Uniqure Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Haemophilia A Table 3. Key Players of Haemophilia B Table 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2017-2022) Table 8. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2023-2028) Table 10. Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends Table 11. Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers Table 12. Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges Table 13. Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints Table 14. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players (2017-2022) Table 16. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2021) Table 17. Ranking of Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service Table 21. Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2017-2022) Table 25. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2023-2028) Table 27. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2017-2022) Table 29. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2023-2028) Table 31. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Pfizer Company Detail Table 42. Pfizer Business Overview Table 43. Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 44. Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 45. Pfizer Recent Development Table 46. Novo Nordisk Company Detail Table 47. Novo Nordisk Business Overview Table 48. Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 49. Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 50. Novo Nordisk Recent Development Table 51. Baxalta Company Detail Table 52. Baxalta Business Overview Table 53. Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 54. Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 55. Baxalta Recent Development Table 56. Bayer Company Detail Table 57. Bayer Business Overview Table 58. Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 59. Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 60. Bayer Recent Development Table 61. Biogen Company Detail Table 62. Biogen Business Overview Table 63. Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 64. Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 65. Biogen Recent Development Table 66. CSL Behring Company Detail Table 67. CSL Behring Business Overview Table 68. CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 69. CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 70. CSL Behring Recent Development Table 71. Emergent Biosolutions Company Detail Table 72. Emergent Biosolutions Business Overview Table 73. Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 74. Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 75. Emergent Biosolutions Recent Development Table 76. Spark therapeutics Company Detail Table 77. Spark therapeutics Business Overview Table 78. Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 79. Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 80. Spark therapeutics Recent Development Table 81. Uniqure Company Detail Table 82. Uniqure Business Overview Table 83. Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Product Table 84. Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million) Table 85. Uniqure Recent Development Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type: 2021 VS 2028 Figure 2. Haemophilia A Features Figure 3. Haemophilia B Features Figure 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application in 2021 & 2028 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Ambulatory Surgical Centers Case Studies Figure 8. Hemophilia A and B Recombinant Factor Replacement Therapy Report Years Considered Figure 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region: 2021 VS 2028 Figure 12. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players in 2021 Figure 13. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2021 Figure 15. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028) Figure 17. United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028) Figure 21. Germany Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2017-2028) Figure 29. China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028) Figure 37. Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028) Figure 41. Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Pfizer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 44. Novo Nordisk Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 45. Baxalta Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 46. Bayer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 47. Biogen Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 48. CSL Behring Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 49. Emergent Biosolutions Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 50. Spark therapeutics Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 51. Uniqure Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Pfizer Novo Nordisk Baxalta Bayer Biogen CSL Behring Emergent Biosolutions Spark therapeutics Uniqure